SlideShare a Scribd company logo
Building	
  Public	
  Safety	
  and	
  Public	
  Health	
  
 Partnerships	
  to	
  Reduce	
  Prescrip9on	
  
                 Drug	
  Abuse	
  
                             Laurence	
  Busching	
  
    First	
  Deputy	
  Criminal	
  Jus2ce	
  Coordinator,	
  City	
  of	
  New	
  York	
  

                                   Denise	
  Paone	
  
     Director	
  of	
  Research	
  and	
  Surveillance,	
  Bureau	
  of	
  Alcohol	
  
     and	
  Drug	
  Use	
  Preven2on,	
  Care	
  and	
  Treatment,	
  New	
  York	
  
            City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  

                                 Dr.	
  Jessica	
  Ka@an	
  	
  
        	
  CDC	
  Health	
  Systems	
  Integra2on	
  Program	
  Scholar,	
  
      Centers	
  for	
  Disease	
  Control	
  and	
  Preven2on,	
  SciMetrika	
  
                                      Contractor,	
  
       Assigned	
  to	
  New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  
                                 Mental	
  Hygiene.	
  
How	
  To	
  Work	
  with	
  Public	
  Health	
  
       Data	
  in	
  Inves9ga9ons	
  
              April	
  2	
  –	
  4,	
  2013	
  
            Omni	
  Orlando	
  Resort	
  	
  
             at	
  ChampionsGate	
  
Learning	
  Objec9ves	
  
•  Outline	
  strategies	
  to	
  create	
  alliances	
  across	
  
   agency	
  lines.	
  
•  Explain	
  how	
  to	
  leverage	
  public	
  health	
  data	
  in	
  
   inves2ga2ons.	
  
•  Outline	
  the	
  importance	
  of	
  collabora2on	
  
   between	
  public	
  health	
  officials	
  and	
  law	
  
   enforcement	
  in	
  inves2ga2ons.	
  


                                                                            3	
  
Disclosure	
  Statement	
  
Laurence	
  Busching,	
  Dr.	
  Jessica	
  KaXan,	
  Dr.	
  Denise	
  
Paone,	
  Chauncey	
  Parker,	
  and	
  Edward	
  Carrasco	
  
have	
  no	
  financial	
  rela2onships	
  with	
  proprietary	
  
en22es	
  that	
  produce	
  health	
  care	
  goods	
  and	
  
services.	
  




                                                                         4	
  
Outline	
  
•  The	
  Threat	
  in	
  New	
  York	
  City	
  
   	
  (Dr.	
  Denise	
  Paone,	
  NYC	
  DOHMH)	
  
•  Mayor’s	
  Task	
  Force	
  on	
  Prescrip9on	
  Painkiller	
  Abuse	
  
   	
  (Laurence	
  Busching,	
  New	
  York	
  City’s	
  Mayor’s	
  Office)	
  
•  Public	
  Health/Public	
  Safety	
  Ini9a9ves	
  
    –  RxStat	
  (Dr.	
  Denise	
  Paone,	
  NYC	
  DOHMH)	
  
    –  Prescribing	
  Guidelines	
  (Dr.	
  Jessica	
  KaCan,	
  NYC	
  DOHMH)	
  
    –  Public	
  Safety	
  (Chauncey	
  Parker,	
  NY/NJ	
  HIDTA)	
  
    –  NYPD	
  Ini9a9ves	
  (Edward	
  Carrasco,	
  NYPD)	
  
•  Public	
  Health/Public	
  Safety	
  Partnerships	
  
                                                                                     5	
  
Dr.	
  Denise	
  Paone,	
  Director	
  of	
  Research	
  and	
  Surveillance	
  
New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  

THE	
  THREAT	
  IN	
  NEW	
  YORK	
  CITY	
  	
  
Opioid	
  analgesic	
  misuse	
  and	
  the	
  
associated	
  consequences	
  have	
  led	
  
    to	
  a	
  public	
  health	
  crisis	
  in	
  	
  
                New	
  York	
  City.	
  



                                                          7	
  
•  From	
  2005-­‐2011,	
  the	
  rate	
  of	
  opioid	
  analgesic	
  
   overdose	
  deaths	
  increased	
  65%,	
  heroin	
  
   overdose	
  deaths	
  decreased	
  8%.	
  

•  In	
  2011,	
  more	
  than	
  one	
  fatal	
  opioid	
  analgesic	
  
   overdose	
  occurred	
  every	
  other	
  day	
  in	
  New	
  
   York	
  City.	
  

•  In	
  2005,	
  opioid	
  analgesics	
  were	
  involved	
  in	
  
   16%	
  of	
  overdose	
  deaths;	
  in	
  2011,	
  they	
  were	
  
   involved	
  in	
  35%.	
  

                                                                            8	
  
Exis9ng	
  Data/Surveillance	
  on	
  Opioid	
  
  Analgesic	
  (Pain	
  Reliever)	
  Misuse	
  
                     Overdose	
  
 Mortality	
                           Death	
  Cer2ficates	
  
                      deaths?	
  
                      Health	
        ED	
  Visits,	
  Treatment	
  
Morbidity	
                                  Admissions	
  
                  consequences?	
  
                   Prescrip2ons	
  
Prescribing	
                               PDMP	
  Data	
  
                      Filled?	
  
                    How	
  Many	
     Na2onal	
  Survey	
  on	
  
Prevalence	
                           Drug	
  User	
  Health	
  
                     Users?	
  



                                                                       9	
  
Overdose	
  Deaths	
  Decreased	
  22%	
  in	
  NYC	
  
            500	
                                                                                          Cocaine	
  
                                                                                                           Heroin	
  
                                                                                                           Methadone	
  
            400	
  
                                                                                                           Benzodiazepines	
  
                                                                                                           Opioid	
  Analgesics	
  
            300	
  
Number	
  	
  




            200	
  


            100	
  
                              Drugs	
  are	
  not	
  mutually	
  exclusive	
  	
  
                 0	
  
                   2005	
                2006	
               2007	
                 2008	
     2009	
         2010	
                 2011	
  
                                                                                 Year	
  


Source: New York City Office of the Chief Medical Examiner &
New York City Department of Health and Mental Hygiene 2005-2011
                                                                                                                                          10	
  
Opioid	
  analgesic	
  overdose	
  deaths	
  increased	
  65%	
  

             250	
                                                                                                                            4.0	
  
                         Opioid	
  analgesic	
  overdose	
  deaths,	
  NYC,	
  2005-­‐2011	
  	
  3.3	
  
                                                                                                                                              3.5	
  
             200	
  
                                                                                                                                              3.0	
  
                                                                                                                         2.6	
  
                                                                                                       2.4	
  




                                                                                                                                                        Age-­‐Adjusted	
  Rate	
  per	
  100,000	
  
                                             2.3	
                                                                                            2.5	
  
             150	
                                                                  2.0	
  
                          2.0	
                                  2.0	
  
                                                                                                                                              2.0	
  
Number	
  




             100	
                                                                                                                            1.5	
  

                                                                                                                                              1.0	
  
               50	
  
                                                                                                                                              0.5	
  
                         130	
               152	
              131	
               137	
              158	
            173	
      220	
  
                 0	
                                                                                                                          0.0	
  
                         2005	
             2006	
             2007	
              2008	
             2009	
            2010	
     2011	
  
                                    Number	
  of	
  opioid	
  analgesic	
  overdose	
  deaths	
  

                                    Age-­‐adjusted	
  opioid	
  analgesic	
  rates	
  per	
  100,000	
  popula9on	
  


Source: New York City Office of the Chief Medical Examiner &
New York City Department of Health and Mental Hygiene 2005-2011
                                                                                                                                                   11	
  
Opioid	
  Analgesic-­‐related	
  Emergency	
  Department	
  
                   Visit	
  Rates	
  Doubled	
  from	
  2004	
  to	
  2010	
  	
  
                            Opioid	
  analgesic	
  misuse/abuse	
  emergency	
  department	
  visits,	
  
         12,000	
                                       NYC	
  2004-­‐2010	
                  129.2	
                                    140.0	
  

                                                                                                113.1	
         110.3	
                  120.0	
  




                                                                                                                                                     Age-­‐adjusted	
  rate	
  per	
  100,000	
  	
  	
  	
  
         10,000	
  
                                                                             103.2	
  
                                                           89.8	
                                                                        100.0	
  
              8,000	
  
                                         79.8	
  
 Number	
  




                                                                                                                                         80.0	
  
              6,000	
  
                              54.7	
                                                                                        10,843	
     60.0	
  
                                                                                                9,442	
         9,254	
  
              4,000	
                                                        8,577	
  
                                                          7,411	
                                                                        40.0	
  
                                         6,560	
  
              2,000	
        4,466	
  
                                                                                                                                         20.0	
  

                    0	
                                                                                                                  0.0	
  
                              2004	
     2005	
         2006	
             2007	
             2008	
            2009	
       2010	
  
                                                     Number	
  of	
  opioid	
  analgesics	
  ED	
  visits	
  



Source: Drug Abuse Warning Network, Center for Behavioral Health Statistics and
Quality, Substance Abuse Mental Health Services Administration, 2004-2010
                                                                                                                                                                                                                12	
  
Oxycodone	
  prescrip9ons	
  increased	
  
                                51%	
  from	
  2008	
  to	
  2010	
  in	
  NYC	
  
                        2,500,000	
  



                        2,000,000	
  
                                                                                           All	
  prescrip9ons	
  
prescrip9ons	
  
 Number	
  of	
  	
  




                        1,500,000	
  


                                                                                                 Oxycodone	
  
                        1,000,000	
  


                                                                                                Hydrocodone	
  
                          500,000	
  
                                    2008	
                               2009	
                             2010	
  


                                                                   Year	
  Dispensed	
  

 Source: New York State Department of Health, Bureau of Narcotic
 Enforcement, Prescription Drug Monitoring Program, 2008-2010                                                   13	
  
15%	
  of	
  prescribers	
  write	
  82%	
  of	
  
                  opioid	
  analgesic	
  prescrip9ons	
  
                                Prescrip2ons	
  filled	
  by	
  NYC	
  residents,	
  2010	
  
          100%                              1%

          90%      15%	
                   14%
                                                              Very Frequent
                                                              Prescribers
                                                                                       31%
                                                              530-10,185 RX/year
          80%
          70%                                                 Frequent
                                           36%                Prescribers
          60%                                                 50-529 RX/year                       82%	
  
Percent




          50%                                                 Occasional
                                                              Prescribers              51%
          40%
                                                              4-49 RX/year
          30%
                                           49%                Rare Prescribers
          20%                                                 1-3 RX/year
          10%                                                                          15%

           0%                                                                           2%

                                    Prescribers                                    Prescriptions
                                                        Prescribing frequency


Source: New York State Department of Health, Bureau of Narcotic
Enforcement, Prescription Drug Monitoring Program, 2008-2010                                                 14	
  
Neighborhoods	
  with	
  Highest	
  Rates	
  of	
  Opioid	
  
  Prescrip9ons	
  have	
  Highest	
  Rates	
  of	
  Overdose	
  Deaths	
  
 Rates	
  of	
  prescrip9ons	
  filled	
  for	
  opioid	
              Rates	
  of	
  uninten9onal	
  opioid	
  
   analgesics	
  by	
  NYC	
  neighborhood         	
               analgesic	
  overdose	
  deaths	
  by	
  NYC	
  
                                                                                 neighborhood    	
  




Source: New York State Department of Health, Bureau of Narcotic
Enforcement, Prescription Drug Monitoring Program, 2008-2009;
New York City Office of the Chief Medical Examiner &New York City
Department of Health and Mental Hygiene 2008-2009                                                                      15	
  
Most	
  Commonly	
  Used	
  Drugs	
  Are	
  	
  
                                       Opioid	
  Analgesics	
  
                  5%	
       Self-­‐reported	
  drug	
  use	
  in	
  past	
  12	
  months,	
  NYC,	
  aged	
  12+	
  
                                                                                                       Opioid	
  Analgesics	
  
                  4%	
  


                  3%	
  
                                                                                                                    Cocaine	
  
Percent	
  	
  




                  2%	
  

                                                                                                            Benzodiazepines	
  
                  1%	
  

                                                                                                                      Heroin	
  
                  0%	
  
                    2002-­‐03	
              2004-­‐05	
                2006-­‐07	
         2008-­‐09	
                  2010-­‐11	
  

                                      Self-­‐reported	
  year	
  of	
  use	
  (two	
  year	
  average)	
  
  Source: Substance Abuse Mental Health Services Administration, Office of
  Applied Studies, 2002-2009 National Surveys on Drug Use and Health                                                                     16	
  
Laurence	
  Busching,	
  First	
  Deputy	
  Criminal	
  Jus2ce	
  Coordinator	
  
New	
  York	
  City	
  Office	
  of	
  the	
  Mayor	
  

NYC	
  MAYOR’S	
  TASK	
  FORCE	
  ON	
  
PRESCRIPTION	
  PAINKILLER	
  ABUSE	
  
NYC	
  Mayor’s	
  Task	
  Force	
  on	
  
      Prescrip9on	
  Painkiller	
  Abuse	
  
Co-­‐chair,	
  Criminal	
  Jus2ce	
  Coordinator	
  
Co-­‐chair,	
  Deputy	
  Mayor	
  for	
  Health	
  and	
  Human	
  Services	
  
New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  
New	
  York	
  City	
  Police	
  Department	
  	
  
New	
  York	
  City	
  Department	
  of	
  Educa2on	
  	
  
Health	
  and	
  Hospitals	
  Corpora2on	
  
Human	
  Resources	
  Administra2on	
  
Mayor’s	
  Office	
  of	
  Policy	
  and	
  Strategic	
  Planning	
  
Richmond	
  County	
  District	
  AXorney’s	
  Office	
  
Office	
  of	
  the	
  Special	
  Narco2cs	
  Prosecutor	
  
Drug	
  Enforcement	
  Administra2on	
  
NY/NJ	
  HIDTA	
                                                                    18	
  
Task	
  Force	
  Work	
  Groups	
  
•  Data	
  
•  Legisla9on	
  	
  
•  Preven9on	
  and	
  Treatment	
  
•  Law	
  Enforcement	
  	
  




                                                    19	
  
Dr.	
  Denise	
  Paone,	
  Director	
  of	
  Research	
  and	
  Surveillance	
  
New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  

RXSTAT:	
  NYC’S	
  COMPREHENSIVE	
  
DRUG	
  SURVEILLANCE	
  SYSTEM	
  
“COMPSTAT	
  for	
  PrescripNon	
  Drug	
  Abuse”	
  
RxStat	
  Goals	
  
      “COMPSTAT	
  for	
  PrescripNon	
  Drug	
  Abuse”	
  	
  
Reduce	
  prescrip+on	
  drug	
  misuse	
  in	
  NYC	
  and	
  
associated	
  health	
  and	
  safety	
  consequences	
  by:	
  
•  Facilita2ng	
  accurate	
  and	
  2mely	
  analysis	
  of	
  
   public	
  health	
  and	
  public	
  safety	
  data.	
  
•  Targe2ng	
  resources	
  and	
  coordina2ng	
  efforts	
  to	
  
   provide	
  the	
  most	
  effec2ve	
  and	
  efficient	
  City	
  
   response.	
  
•  Providing	
  measures	
  to	
  track	
  strategies.	
  
                                                                     21	
  
RxStat	
  
     “COMPSTAT	
  for	
  PrescripNon	
  Drug	
  Abuse”	
  	
  
•  Public	
  Health	
  &	
  Public	
  Safety	
  Collabora2on.	
  

•  “Real-­‐2me”	
  (enhanced)	
  surveillance.	
  

•  Par2cipants	
  and	
  stakeholders	
  at	
  city,	
  state,	
  
   and	
  federal	
  organiza2ons.	
  

•  Monthly	
  RxStat	
  mee2ngs	
  with	
  key	
  
   stakeholders.	
  
                                                                     22	
  
Enhanced	
  Surveillance	
  Efforts	
  
                                                         Monthly	
  Monitoring,	
  OCME	
  BoXle	
  
     Mortality	
  
                                                                      Project*	
  
                                                         Daily	
  ED	
  Visits,	
  Daily	
  NYC	
  PCC	
  Calls,	
  
    Morbidity	
  
                                                          Quarterly	
  Treatment	
  Admissions	
  
                                                            Quarterly	
  PDMP	
  data,	
  Quarterly	
  
   Prescribing	
                                                          DEA	
  Data	
  
 Prevalence	
  &	
                                             Qualita2ve	
  Component,	
  Data	
  
  Intelligence	
                                                    Analy2cs/Mapping	
  	
  
    Crime	
  &	
                                        Monthly	
  Prosecu2ons*,	
  NYPD	
  Data,	
  
   Diversion	
                                           Quarterly	
  DEA	
  Losses,	
  Rx	
  Crimes*	
  



*Discussed	
  in	
  more	
  detail	
  later	
  in	
  the	
  presentaNon.	
  
                                                                                                                       23	
  
RxStat	
  
“COMPSTAT	
  for	
  PrescripNon	
  Drug	
  Abuse”	
  	
  

  RxStat	
  creates	
  a	
  plaqorm	
  for	
  
collabora2ve	
  problem	
  solving	
  to	
  
reduce	
  prescrip2on	
  drug	
  abuse.	
  




                                                            24	
  
Dr.	
  Jessica	
  KaXan,	
  CDC	
  Health	
  Systems	
  Integra2on	
  Program	
  Scholar	
  
Centers	
  for	
  Disease	
  Control	
  and	
  Preven2on,	
  SciMetrika	
  Contractor	
  
Assigned	
  to	
  New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  

BEST	
  PRACTICES	
  PRESCRIBING	
  
GUIDELINES	
  
Opioid	
  Prescribing	
  Guidelines	
  




                                          26	
  
Emergency	
  Department	
  Opioid	
  Prescribing	
  
     Guidelines:	
  Goal	
  and	
  Ra9onale	
  
  •  Establish	
  standards	
  for	
  prescribing.	
  
  •  Balance	
  pain	
  treatment	
  with	
  reducing	
  opioid	
  
     analgesic	
  misuse.	
  
  •  Why	
  Emergency	
  Departments?	
  
     –  Pain	
  is	
  a	
  common	
  presenta2on	
  in	
  EDs.	
  	
  
     –  Opioid	
  analgesics	
  are	
  commonly	
  prescribed	
  in	
  EDs,	
  
        although	
  EDs	
  not	
  the	
  main	
  source.	
  
     –  One	
  component	
  of	
  a	
  mul2-­‐pronged	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
        approach.	
  
                                                                                                27	
  
Target	
  &	
  Adop9on	
  
•  Pa2ents	
  discharged	
  from	
  EDs.	
  

•  Not	
  meant	
  for	
  pallia2ve	
  care	
  programs	
  or	
  
   cancer	
  pain.	
  

•  Adopted	
  by	
  all	
  Health	
  and	
  Hospitals	
  
   Corpora2on	
  EDs	
  (NYC’s	
  public	
  hospital	
  system).	
  



                                                                    28	
  
ED	
  Opioid	
  Prescribing	
  Guidelines	
  




                                                29	
  
Percep9ons	
  
•  Emergency	
  Departments	
  

•  Media	
  Response	
  

•  General	
  Public	
  


                                   30	
  
Chauncey	
  Parker,	
  Director	
  
New	
  York/New	
  Jersey	
  High	
  Intensity	
  Drug	
  Trafficking	
  Area	
  

APPLICATION	
  IN	
  PUBLIC	
  SAFETY	
  &	
  
RX	
  CRIMES	
  
Overdose	
  Death	
  Prescrip9ons	
  
•  Office	
  of	
  the	
  Chief	
  Medical	
  Examiner	
  (OCME)	
  
   began	
  collec2ng	
  prescrip2on	
  boXles	
  at	
  death	
  
   scenes.	
  

•  Partnership	
  allowed	
  resources	
  to	
  log	
  the	
  
   boXle	
  informa2on.	
  

•  Data	
  in	
  process	
  of	
  being	
  compiled	
  as	
  poten2al	
  
   supplemental	
  intelligence.	
  	
  

                                                                            32	
  
New	
  York	
  County	
  2012	
  Drug	
  
                                  Prosecu9ons	
  by	
  Drug	
  Type	
  
                                     (reflec2ng	
  11,712	
  instances	
  of	
  drugs	
  in	
  10,559	
  prosecu2ons)	
  




“Benzodiazepines”	
  includes	
  Alprazolam,	
  Clonazepam,	
  Diazepam,	
  etc.	
  
“Opioid	
  Analgesics”	
  includes	
  pure	
  &	
  compound	
  versions	
  of	
  Oxycodone,	
  Hydrocodone,	
  Oxymorphone,	
  Morphine,	
  etc.	
  (excludes	
  Methadone).	
     33	
  
Oxycodone	
  &	
  Oxycodone	
  Compounds	
  Arrest	
  Loca9ons	
  
 Reflec9ng	
  160	
  Prosecu9ons	
  in	
  Three	
  Upper	
  Manha@an	
  Precincts	
  




                                                                                       34	
  
Rx	
  Crimes	
  	
  
•  Central	
  repository	
  for	
  Rx-­‐related	
  
   Robberies/Burglaries,	
  direct	
  LEA	
  
   access	
  to	
  police	
  reports.	
  
•  Fill	
  cross-­‐border/interagency	
  
   sharing	
  gap.	
  
•  Allow	
  proac2ve	
  analysis:	
  
    — Emerging	
  crime	
  paXerns	
  
       (e.g.,	
  through	
  the	
  roof)	
  
    — Security	
  alerts	
  
    — Sources	
  of	
  drugs	
  
    — Targeted	
  drugs	
  


                                                         35	
  
Edward	
  Carrasco,	
  Deputy	
  Inspector	
  
Office	
  of	
  Management	
  Analysis	
  and	
  Planning	
  
New	
  York	
  Police	
  Department	
  

NEW	
  YORK	
  POLICE	
  DEPARTMENT	
  
RX	
  DRUG	
  INITIATIVES	
  
NYPD	
  Rx	
  Drug	
  Ini9a9ves	
  

Emphasis	
  on	
  Community	
  Engagement	
  

  •  Partnership	
  with	
  schools	
  

  •  Pharmacy	
  Crimes	
  Reduc2on	
  Ini2a2ve	
  

  •  Other	
  awareness	
  programs	
  


                                                      37	
  
Laurence	
  Busching,	
  First	
  Deputy	
  Criminal	
  Jus2ce	
  Coordinator	
  
New	
  York	
  City	
  Office	
  of	
  the	
  Mayor	
  

PUBLIC	
  HEALTH	
  &	
  PUBLIC	
  SAFETY	
  
PARTNERSHIPS	
  
Challenges	
  &	
  	
  Conclusions	
  
•    Legality	
  of	
  prescrip2on	
  drugs	
  
•    Complexi2es	
  of	
  regula2on	
  
•    Data	
  availability/data	
  silos	
  
•    Terminology	
  across	
  fields	
  
•    Addressing	
  misinforma2on	
  
•    Developing	
  collabora2ve	
  approaches	
  

 Common	
  Goal	
  -­‐	
  	
  
 Reduce	
  prescrip+on	
  drug	
  abuse	
  and	
  the	
  
 associated	
  public	
  health	
  and	
  public	
  safety	
  
 consequences.	
  	
                                             39	
  
Ques9ons	
  




For	
  more	
  informa2on	
  contact:	
  
John	
  Hreno	
  -­‐	
  jhreno@nynjhidta.org	
  
                                                   40	
  

More Related Content

Similar to Building public safety_public_health_partnerships_final

Ph 2 paulozzi paone_kelly
Ph 2 paulozzi paone_kellyPh 2 paulozzi paone_kelly
Ph 2 paulozzi paone_kelly
OPUNITE
 
Tue gs volkow
Tue gs volkowTue gs volkow
Tue gs volkow
OPUNITE
 
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasRx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
OPUNITE
 
Colleen Fuller - Pharmacare in Canada Today
Colleen Fuller - Pharmacare in Canada TodayColleen Fuller - Pharmacare in Canada Today
Colleen Fuller - Pharmacare in Canada Today
Pharmacare 2020
 
R. Gil Kerlikowske
R. Gil KerlikowskeR. Gil Kerlikowske
R. Gil Kerlikowske
OPUNITE
 
Drug education and prevention in England
Drug education and prevention in England Drug education and prevention in England
Drug education and prevention in England
Mentor
 
Addressing Co Morbidity In The EAP Setting Cambridge College Class Slides
Addressing Co Morbidity In The EAP Setting   Cambridge College Class SlidesAddressing Co Morbidity In The EAP Setting   Cambridge College Class Slides
Addressing Co Morbidity In The EAP Setting Cambridge College Class Slides
Bernie McCann
 
Realities of addiction_volkow-final
Realities of addiction_volkow-finalRealities of addiction_volkow-final
Realities of addiction_volkow-final
OPUNITE
 
Policies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_revPolicies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_rev
OPUNITE
 
Peter Kreiner
Peter KreinerPeter Kreiner
Peter Kreiner
OPUNITE
 
Andrew Kolodny
Andrew KolodnyAndrew Kolodny
Andrew Kolodny
OPUNITE
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
ShirazKhokhar1
 
Cleveland Plus March 2009 Quarterly Economic Review
Cleveland Plus March 2009 Quarterly Economic ReviewCleveland Plus March 2009 Quarterly Economic Review
Cleveland Plus March 2009 Quarterly Economic Review
Team NEO
 

Similar to Building public safety_public_health_partnerships_final (13)

Ph 2 paulozzi paone_kelly
Ph 2 paulozzi paone_kellyPh 2 paulozzi paone_kelly
Ph 2 paulozzi paone_kelly
 
Tue gs volkow
Tue gs volkowTue gs volkow
Tue gs volkow
 
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznasRx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
Rx15 vision wed_200_ondcp_1_labelle_2jones_3spitznas
 
Colleen Fuller - Pharmacare in Canada Today
Colleen Fuller - Pharmacare in Canada TodayColleen Fuller - Pharmacare in Canada Today
Colleen Fuller - Pharmacare in Canada Today
 
R. Gil Kerlikowske
R. Gil KerlikowskeR. Gil Kerlikowske
R. Gil Kerlikowske
 
Drug education and prevention in England
Drug education and prevention in England Drug education and prevention in England
Drug education and prevention in England
 
Addressing Co Morbidity In The EAP Setting Cambridge College Class Slides
Addressing Co Morbidity In The EAP Setting   Cambridge College Class SlidesAddressing Co Morbidity In The EAP Setting   Cambridge College Class Slides
Addressing Co Morbidity In The EAP Setting Cambridge College Class Slides
 
Realities of addiction_volkow-final
Realities of addiction_volkow-finalRealities of addiction_volkow-final
Realities of addiction_volkow-final
 
Policies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_revPolicies and laws_for_pharmacists_final_rev
Policies and laws_for_pharmacists_final_rev
 
Peter Kreiner
Peter KreinerPeter Kreiner
Peter Kreiner
 
Andrew Kolodny
Andrew KolodnyAndrew Kolodny
Andrew Kolodny
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
 
Cleveland Plus March 2009 Quarterly Economic Review
Cleveland Plus March 2009 Quarterly Economic ReviewCleveland Plus March 2009 Quarterly Economic Review
Cleveland Plus March 2009 Quarterly Economic Review
 

More from OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
OPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
OPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
OPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
OPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
OPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
OPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
OPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
OPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
OPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 

More from OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Building public safety_public_health_partnerships_final

  • 1. Building  Public  Safety  and  Public  Health   Partnerships  to  Reduce  Prescrip9on   Drug  Abuse   Laurence  Busching   First  Deputy  Criminal  Jus2ce  Coordinator,  City  of  New  York   Denise  Paone   Director  of  Research  and  Surveillance,  Bureau  of  Alcohol   and  Drug  Use  Preven2on,  Care  and  Treatment,  New  York   City  Department  of  Health  and  Mental  Hygiene   Dr.  Jessica  Ka@an      CDC  Health  Systems  Integra2on  Program  Scholar,   Centers  for  Disease  Control  and  Preven2on,  SciMetrika   Contractor,   Assigned  to  New  York  City  Department  of  Health  and   Mental  Hygiene.  
  • 2. How  To  Work  with  Public  Health   Data  in  Inves9ga9ons   April  2  –  4,  2013   Omni  Orlando  Resort     at  ChampionsGate  
  • 3. Learning  Objec9ves   •  Outline  strategies  to  create  alliances  across   agency  lines.   •  Explain  how  to  leverage  public  health  data  in   inves2ga2ons.   •  Outline  the  importance  of  collabora2on   between  public  health  officials  and  law   enforcement  in  inves2ga2ons.   3  
  • 4. Disclosure  Statement   Laurence  Busching,  Dr.  Jessica  KaXan,  Dr.  Denise   Paone,  Chauncey  Parker,  and  Edward  Carrasco   have  no  financial  rela2onships  with  proprietary   en22es  that  produce  health  care  goods  and   services.   4  
  • 5. Outline   •  The  Threat  in  New  York  City    (Dr.  Denise  Paone,  NYC  DOHMH)   •  Mayor’s  Task  Force  on  Prescrip9on  Painkiller  Abuse    (Laurence  Busching,  New  York  City’s  Mayor’s  Office)   •  Public  Health/Public  Safety  Ini9a9ves   –  RxStat  (Dr.  Denise  Paone,  NYC  DOHMH)   –  Prescribing  Guidelines  (Dr.  Jessica  KaCan,  NYC  DOHMH)   –  Public  Safety  (Chauncey  Parker,  NY/NJ  HIDTA)   –  NYPD  Ini9a9ves  (Edward  Carrasco,  NYPD)   •  Public  Health/Public  Safety  Partnerships   5  
  • 6. Dr.  Denise  Paone,  Director  of  Research  and  Surveillance   New  York  City  Department  of  Health  and  Mental  Hygiene   THE  THREAT  IN  NEW  YORK  CITY    
  • 7. Opioid  analgesic  misuse  and  the   associated  consequences  have  led   to  a  public  health  crisis  in     New  York  City.   7  
  • 8. •  From  2005-­‐2011,  the  rate  of  opioid  analgesic   overdose  deaths  increased  65%,  heroin   overdose  deaths  decreased  8%.   •  In  2011,  more  than  one  fatal  opioid  analgesic   overdose  occurred  every  other  day  in  New   York  City.   •  In  2005,  opioid  analgesics  were  involved  in   16%  of  overdose  deaths;  in  2011,  they  were   involved  in  35%.   8  
  • 9. Exis9ng  Data/Surveillance  on  Opioid   Analgesic  (Pain  Reliever)  Misuse   Overdose   Mortality   Death  Cer2ficates   deaths?   Health   ED  Visits,  Treatment   Morbidity   Admissions   consequences?   Prescrip2ons   Prescribing   PDMP  Data   Filled?   How  Many   Na2onal  Survey  on   Prevalence   Drug  User  Health   Users?   9  
  • 10. Overdose  Deaths  Decreased  22%  in  NYC   500   Cocaine   Heroin   Methadone   400   Benzodiazepines   Opioid  Analgesics   300   Number     200   100   Drugs  are  not  mutually  exclusive     0   2005   2006   2007   2008   2009   2010   2011   Year   Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene 2005-2011 10  
  • 11. Opioid  analgesic  overdose  deaths  increased  65%   250   4.0   Opioid  analgesic  overdose  deaths,  NYC,  2005-­‐2011    3.3   3.5   200   3.0   2.6   2.4   Age-­‐Adjusted  Rate  per  100,000   2.3   2.5   150   2.0   2.0   2.0   2.0   Number   100   1.5   1.0   50   0.5   130   152   131   137   158   173   220   0   0.0   2005   2006   2007   2008   2009   2010   2011   Number  of  opioid  analgesic  overdose  deaths   Age-­‐adjusted  opioid  analgesic  rates  per  100,000  popula9on   Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene 2005-2011 11  
  • 12. Opioid  Analgesic-­‐related  Emergency  Department   Visit  Rates  Doubled  from  2004  to  2010     Opioid  analgesic  misuse/abuse  emergency  department  visits,   12,000   NYC  2004-­‐2010   129.2   140.0   113.1   110.3   120.0   Age-­‐adjusted  rate  per  100,000         10,000   103.2   89.8   100.0   8,000   79.8   Number   80.0   6,000   54.7   10,843   60.0   9,442   9,254   4,000   8,577   7,411   40.0   6,560   2,000   4,466   20.0   0   0.0   2004   2005   2006   2007   2008   2009   2010   Number  of  opioid  analgesics  ED  visits   Source: Drug Abuse Warning Network, Center for Behavioral Health Statistics and Quality, Substance Abuse Mental Health Services Administration, 2004-2010 12  
  • 13. Oxycodone  prescrip9ons  increased   51%  from  2008  to  2010  in  NYC   2,500,000   2,000,000   All  prescrip9ons   prescrip9ons   Number  of     1,500,000   Oxycodone   1,000,000   Hydrocodone   500,000   2008   2009   2010   Year  Dispensed   Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, 2008-2010 13  
  • 14. 15%  of  prescribers  write  82%  of   opioid  analgesic  prescrip9ons   Prescrip2ons  filled  by  NYC  residents,  2010   100% 1% 90% 15%   14% Very Frequent Prescribers 31% 530-10,185 RX/year 80% 70% Frequent 36% Prescribers 60% 50-529 RX/year 82%   Percent 50% Occasional Prescribers 51% 40% 4-49 RX/year 30% 49% Rare Prescribers 20% 1-3 RX/year 10% 15% 0% 2% Prescribers Prescriptions Prescribing frequency Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, 2008-2010 14  
  • 15. Neighborhoods  with  Highest  Rates  of  Opioid   Prescrip9ons  have  Highest  Rates  of  Overdose  Deaths   Rates  of  prescrip9ons  filled  for  opioid   Rates  of  uninten9onal  opioid   analgesics  by  NYC  neighborhood   analgesic  overdose  deaths  by  NYC   neighborhood   Source: New York State Department of Health, Bureau of Narcotic Enforcement, Prescription Drug Monitoring Program, 2008-2009; New York City Office of the Chief Medical Examiner &New York City Department of Health and Mental Hygiene 2008-2009 15  
  • 16. Most  Commonly  Used  Drugs  Are     Opioid  Analgesics   5%   Self-­‐reported  drug  use  in  past  12  months,  NYC,  aged  12+   Opioid  Analgesics   4%   3%   Cocaine   Percent     2%   Benzodiazepines   1%   Heroin   0%   2002-­‐03   2004-­‐05   2006-­‐07   2008-­‐09   2010-­‐11   Self-­‐reported  year  of  use  (two  year  average)   Source: Substance Abuse Mental Health Services Administration, Office of Applied Studies, 2002-2009 National Surveys on Drug Use and Health 16  
  • 17. Laurence  Busching,  First  Deputy  Criminal  Jus2ce  Coordinator   New  York  City  Office  of  the  Mayor   NYC  MAYOR’S  TASK  FORCE  ON   PRESCRIPTION  PAINKILLER  ABUSE  
  • 18. NYC  Mayor’s  Task  Force  on   Prescrip9on  Painkiller  Abuse   Co-­‐chair,  Criminal  Jus2ce  Coordinator   Co-­‐chair,  Deputy  Mayor  for  Health  and  Human  Services   New  York  City  Department  of  Health  and  Mental  Hygiene   New  York  City  Police  Department     New  York  City  Department  of  Educa2on     Health  and  Hospitals  Corpora2on   Human  Resources  Administra2on   Mayor’s  Office  of  Policy  and  Strategic  Planning   Richmond  County  District  AXorney’s  Office   Office  of  the  Special  Narco2cs  Prosecutor   Drug  Enforcement  Administra2on   NY/NJ  HIDTA   18  
  • 19. Task  Force  Work  Groups   •  Data   •  Legisla9on     •  Preven9on  and  Treatment   •  Law  Enforcement     19  
  • 20. Dr.  Denise  Paone,  Director  of  Research  and  Surveillance   New  York  City  Department  of  Health  and  Mental  Hygiene   RXSTAT:  NYC’S  COMPREHENSIVE   DRUG  SURVEILLANCE  SYSTEM   “COMPSTAT  for  PrescripNon  Drug  Abuse”  
  • 21. RxStat  Goals   “COMPSTAT  for  PrescripNon  Drug  Abuse”     Reduce  prescrip+on  drug  misuse  in  NYC  and   associated  health  and  safety  consequences  by:   •  Facilita2ng  accurate  and  2mely  analysis  of   public  health  and  public  safety  data.   •  Targe2ng  resources  and  coordina2ng  efforts  to   provide  the  most  effec2ve  and  efficient  City   response.   •  Providing  measures  to  track  strategies.   21  
  • 22. RxStat   “COMPSTAT  for  PrescripNon  Drug  Abuse”     •  Public  Health  &  Public  Safety  Collabora2on.   •  “Real-­‐2me”  (enhanced)  surveillance.   •  Par2cipants  and  stakeholders  at  city,  state,   and  federal  organiza2ons.   •  Monthly  RxStat  mee2ngs  with  key   stakeholders.   22  
  • 23. Enhanced  Surveillance  Efforts   Monthly  Monitoring,  OCME  BoXle   Mortality   Project*   Daily  ED  Visits,  Daily  NYC  PCC  Calls,   Morbidity   Quarterly  Treatment  Admissions   Quarterly  PDMP  data,  Quarterly   Prescribing   DEA  Data   Prevalence  &   Qualita2ve  Component,  Data   Intelligence   Analy2cs/Mapping     Crime  &   Monthly  Prosecu2ons*,  NYPD  Data,   Diversion   Quarterly  DEA  Losses,  Rx  Crimes*   *Discussed  in  more  detail  later  in  the  presentaNon.   23  
  • 24. RxStat   “COMPSTAT  for  PrescripNon  Drug  Abuse”     RxStat  creates  a  plaqorm  for   collabora2ve  problem  solving  to   reduce  prescrip2on  drug  abuse.   24  
  • 25. Dr.  Jessica  KaXan,  CDC  Health  Systems  Integra2on  Program  Scholar   Centers  for  Disease  Control  and  Preven2on,  SciMetrika  Contractor   Assigned  to  New  York  City  Department  of  Health  and  Mental  Hygiene   BEST  PRACTICES  PRESCRIBING   GUIDELINES  
  • 27. Emergency  Department  Opioid  Prescribing   Guidelines:  Goal  and  Ra9onale   •  Establish  standards  for  prescribing.   •  Balance  pain  treatment  with  reducing  opioid   analgesic  misuse.   •  Why  Emergency  Departments?   –  Pain  is  a  common  presenta2on  in  EDs.     –  Opioid  analgesics  are  commonly  prescribed  in  EDs,   although  EDs  not  the  main  source.   –  One  component  of  a  mul2-­‐pronged                     approach.   27  
  • 28. Target  &  Adop9on   •  Pa2ents  discharged  from  EDs.   •  Not  meant  for  pallia2ve  care  programs  or   cancer  pain.   •  Adopted  by  all  Health  and  Hospitals   Corpora2on  EDs  (NYC’s  public  hospital  system).   28  
  • 29. ED  Opioid  Prescribing  Guidelines   29  
  • 30. Percep9ons   •  Emergency  Departments   •  Media  Response   •  General  Public   30  
  • 31. Chauncey  Parker,  Director   New  York/New  Jersey  High  Intensity  Drug  Trafficking  Area   APPLICATION  IN  PUBLIC  SAFETY  &   RX  CRIMES  
  • 32. Overdose  Death  Prescrip9ons   •  Office  of  the  Chief  Medical  Examiner  (OCME)   began  collec2ng  prescrip2on  boXles  at  death   scenes.   •  Partnership  allowed  resources  to  log  the   boXle  informa2on.   •  Data  in  process  of  being  compiled  as  poten2al   supplemental  intelligence.     32  
  • 33. New  York  County  2012  Drug   Prosecu9ons  by  Drug  Type   (reflec2ng  11,712  instances  of  drugs  in  10,559  prosecu2ons)   “Benzodiazepines”  includes  Alprazolam,  Clonazepam,  Diazepam,  etc.   “Opioid  Analgesics”  includes  pure  &  compound  versions  of  Oxycodone,  Hydrocodone,  Oxymorphone,  Morphine,  etc.  (excludes  Methadone).   33  
  • 34. Oxycodone  &  Oxycodone  Compounds  Arrest  Loca9ons   Reflec9ng  160  Prosecu9ons  in  Three  Upper  Manha@an  Precincts   34  
  • 35. Rx  Crimes     •  Central  repository  for  Rx-­‐related   Robberies/Burglaries,  direct  LEA   access  to  police  reports.   •  Fill  cross-­‐border/interagency   sharing  gap.   •  Allow  proac2ve  analysis:   — Emerging  crime  paXerns   (e.g.,  through  the  roof)   — Security  alerts   — Sources  of  drugs   — Targeted  drugs   35  
  • 36. Edward  Carrasco,  Deputy  Inspector   Office  of  Management  Analysis  and  Planning   New  York  Police  Department   NEW  YORK  POLICE  DEPARTMENT   RX  DRUG  INITIATIVES  
  • 37. NYPD  Rx  Drug  Ini9a9ves   Emphasis  on  Community  Engagement   •  Partnership  with  schools   •  Pharmacy  Crimes  Reduc2on  Ini2a2ve   •  Other  awareness  programs   37  
  • 38. Laurence  Busching,  First  Deputy  Criminal  Jus2ce  Coordinator   New  York  City  Office  of  the  Mayor   PUBLIC  HEALTH  &  PUBLIC  SAFETY   PARTNERSHIPS  
  • 39. Challenges  &    Conclusions   •  Legality  of  prescrip2on  drugs   •  Complexi2es  of  regula2on   •  Data  availability/data  silos   •  Terminology  across  fields   •  Addressing  misinforma2on   •  Developing  collabora2ve  approaches   Common  Goal  -­‐     Reduce  prescrip+on  drug  abuse  and  the   associated  public  health  and  public  safety   consequences.     39  
  • 40. Ques9ons   For  more  informa2on  contact:   John  Hreno  -­‐  jhreno@nynjhidta.org   40